当前位置:首页 - 行情中心 - 华兰生物(002007) - 财务分析

华兰生物

(002007)

  

流通市值:269.10亿  总市值:312.50亿
流通股本:15.74亿   总股本:18.27亿

华兰生物(002007)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润5.23亿元,每股收益0.28元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益1397030.39万元,未分配利润788528.00万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1553544.04万元,负债156513.65万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,798,197,926.21867,612,696.574,379,196,621.383,490,648,261.92
营业总成本1,310,025,664.46553,612,323.283,124,967,498.362,431,324,369.49
其他经营收益
营业利润635,103,212.79397,453,634.361,379,582,398.071,221,897,862.21
利润总额611,444,107.03384,573,318.121,338,612,677.841,198,760,719.63
净利润522,691,390.04323,831,368.051,155,469,792.251,011,158,954.78
每股收益
其他综合收益----
综合收益总额522,691,390.04323,831,368.051,155,469,792.251,011,158,954.78
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计9,336,064,233.910,549,823,747.899,616,191,068.199,266,229,186.62
非流动资产:
非流动资产合计6,199,376,166.616,089,097,203.466,693,760,287.16,835,377,216.56
资产总计15,535,440,400.5116,638,920,951.3516,309,951,355.2916,101,606,403.18
流动负债:
流动负债合计1,465,892,254.062,368,375,746.292,360,122,055.572,290,640,060.73
非流动负债:
非流动负债合计99,244,269.7797,975,500.1103,103,316.399,869,441.1
负债合计1,565,136,523.832,466,351,246.392,463,225,371.872,390,509,501.83
所有者权益(或股东权益):
归属于母公司股东权益合计12,013,171,120.8412,172,136,621.0511,858,784,465.4511,697,012,439.64
股东权益合计13,970,303,876.6814,172,569,704.9613,846,725,983.4213,711,096,901.35
负债和股东权益合计15,535,440,400.5116,638,920,951.3516,309,951,355.2916,101,606,403.18
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计2,049,433,728.88852,081,503.325,013,380,402.043,607,081,412.92
经营活动现金流出小计1,818,926,770.1837,902,921.613,954,035,240.163,147,371,986.37
经营活动产生的现金流量净额230,506,958.7814,178,581.711,059,345,161.88459,709,426.55
投资活动产生的现金流量:
投资活动现金流入小计7,502,570,348.644,322,547,185.3623,774,024,671.6618,045,530,207.37
投资活动现金流出小计6,994,719,593.084,679,214,264.9223,683,948,699.8218,026,990,442.39
投资活动产生的现金流量净额507,850,755.56-356,667,079.5690,075,971.8418,539,764.98
筹资活动产生的现金流量:
筹资活动现金流入小计278,159,999.98278,704,844.44612,749,571.01316,281,000
筹资活动现金流出小计1,220,104,824.1197,612,869.431,393,182,691.85944,076,396.8
筹资活动产生的现金流量净额-941,944,824.1281,091,975.01-780,433,120.84-627,795,396.8
汇率变动对现金及现金等价物的影响189,692.0175,438.63-52,406.71-45,954.89
现金及现金等价物净增加额-203,397,417.77-261,321,084.21368,935,606.17-149,592,160.16
期末现金及现金等价物余额1,154,862,803.911,096,939,137.471,358,260,221.68839,732,455.35
补充资料:
现金及现金等价物的净增加额-203,397,417.77-368,935,606.17-
最新报告期:2025-08-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
平安证券叶寅,倪亦道0.680.810.922025-08-28
申万宏源凌静怡0.660.740.832025-08-28
TOP↑